Last reviewed · How we verify

NCT03582501: LBNP

Measurement of Hemodynamic Responses to Lower Body Negative Pressure

Completed NA Last updated 12 June 2019
What this trial tests

NA trial testing Lower body negative pressure in Hypotension and Shock in 24 participants. Completed in 23 May 2019.

Timeline
8 January 2019
Primary endpoint
23 May 2019
23 May 2019

Quick facts

Lead sponsorMayo Clinic
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposebasic science
Enrollment24
Start date8 January 2019
Primary completion23 May 2019
Estimated completion23 May 2019
Sites3 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

Mayo Clinic

Who can join

Adults 18 to 55, any sex, with Hypotension and Shock. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will be collecting data on participants undergoing lower body negative pressure (LBNP) to simulate progressive blood loss. The goal of the study is to collect data to allow for development of an algorithm with machine learning to predict blood pressure responses to hypovolemia by analyzing the arterial waveforms collected during LBNP.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Evidence-based Clinical Decision Support Systems for the prediction and detection of three disease states in critical care: A systematic literature review.
    Medic G, Kosaner Kließ M, Atallah L, Weichert J, et al · · 2019 · cited 20× · PMID 31824670 · DOI 10.12688/f1000research.20498.2

Verify or expand the search:

Other trials of Lower body negative pressure

Trials testing the same drug.

Other recruiting trials for Hypotension and Shock

Currently open trials in the same condition.

Other Mayo Clinic trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03582501.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing